AURKA was found to be upregulated in non-ciliated ovarian and renal cell carcinoma cells [53,54,55,56], and HDAC6 inhibition restored PCs in chondrosarcoma and cholangiocarcinoma cancer cells, suppressing cell proliferation and invasion capacity [57]. Here, HDAC6 is linked to chondrosarcoma.